Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CREB1 inhibitors(cAMP responsive element binding protein 1 inhibitors), CRTC2 inhibitors(CREB regulated transcription coactivator 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Type 2 diabetes mellitus in obese | Preclinical | CN | 11 Jan 2022 |